% | $
Quotes you view appear here for quick access.

Vertex Pharmaceuticals Incorporated Message Board

  • qdelfan qdelfan Aug 16, 2012 9:19 AM Flag

    IDX 184 put on hold by FDA over concern regarding heart issues

    See what's happening to IDIX pps this morning over the concern for cardiac toxicity, which was the reported serious adverses reaction that ended the development of BMY's nuc just a few weeks ago.

    I wonder if a similar concern is about to be announced for GILD's nuc 7977?

    At a mimimum it represents a delay in the approval of the nucs being developed ahead of Vertex hep C next generation products, and extends the life cycle of current treatment regimens for hep C especially for Incivek.

104.40-10.12(-8.84%)11:52 AMEDT